Document Detail

Severe stroke: patient profile and predictors of favorable outcome.
MedLine Citation:
PMID:  23140236     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Severe stroke carries high rates of mortality and morbidity. The aims of this study were to determine the characteristics of patients who initially presented with severe ischemic stroke, and to identify acute and subacute predictors of favorable clinical outcome in these patients.
METHODS: An observational cohort study, Acute Stroke Registry and Analysis of Lausanne (ASTRAL), was analyzed, and all patients presenting with severe stroke - defined as a National Institute of Health Stroke Scale score of ≥ 20 on admission - were compared with all other patients. In a multivariate analysis, associations with demographic, clinical, pathophysiologic, metabolic and neuroimaging factors were determined. Furthermore, we analyzed predictors of favorable outcome (modified Rankin scale score of ≤ 3 at 3 months) in the subgroup of severe stroke patients.
RESULTS:   Of 1915 consecutive patients, 243 (12.7%) presented with severe stroke. This was significantly associated with cardio-embolic stroke mechanism (odds ratio [OR] 1.74, 95% confidence interval [CI] 1.19-2.54), unknown stroke onset (OR 2.35, 95% CI 1.14-4.83), more neuroimaging signs of early ischemia (mostly computed tomography; OR 2.65, 95% CI 1.79-3.92), arterial occlusions on acute imaging (OR 27.01, 95% CI 11.5-62.9), fewer chronic radiologic infarcts (OR 0.43, 95% CI 0.26-0.72), lower hemoglobin concentration (OR 0.97, 95% CI 0.96-0.99), and higher white cell count (OR 1.05, 95% CI 1.00-1.11). In the 68 (28%) patients with favorable outcomes despite presenting with severe stroke, this was predicted by lower age (OR 0.94, 95% CI 0.92-0.97), preceding cerebrovascular events (OR 3.00, 95% CI 1.01-8.97), hypolipemic pretreatment (OR 3.82, 95% CI 1.34-10.90), lower acute temperature (OR 0.43, 95% CI 0.23-0.78), lower subacute glucose concentration (OR 0.74, 95% CI 0.56-0.97), and spontaneous or treatment-induced recanalization (OR 4.51, 95% CI 1.96-10.41).
CONCLUSIONS: Severe stroke presentation is predicted by multiple clinical, radiologic and metabolic variables, several of which are modifiable. Predictors in the 28% of patients with favorable outcome despite presenting with severe stroke include hypolipemic pretreatment, lower acute temperature, lower glucose levels at 24 h, and arterial recanalization.
O Bill; P Zufferey; M Faouzi; P Michel
Related Documents :
3714656 - Increases in serum lipid and lipoprotein levels with movement from the supine to standi...
1854366 - Fat distribution and gender differences in serum lipids in men and women from four euro...
7937426 - Association between serum uric acid and some cardiovascular risk factors in a chinese p...
10454696 - Lipoprotein metabolism during normal pregnancy.
12294006 - Fertility and family planning among jenu kuruba and kadu kuruba tribes of karnataka.
20618316 - Access to computerised analysis of intrapartum cardiotocographs improves clinicians' pr...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of thrombosis and haemostasis : JTH     Volume:  11     ISSN:  1538-7836     ISO Abbreviation:  J. Thromb. Haemost.     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-01-28     Completed Date:  2013-07-26     Revised Date:  2014-07-31    
Medline Journal Info:
Nlm Unique ID:  101170508     Medline TA:  J Thromb Haemost     Country:  England    
Other Details:
Languages:  eng     Pagination:  92-9     Citation Subset:  IM    
Copyright Information:
© 2012 International Society on Thrombosis and Haemostasis.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Age Factors
Aged, 80 and over
Biological Markers / blood
Blood Glucose / analysis
Body Temperature
Cerebral Angiography
Chi-Square Distribution
Disability Evaluation
Hemoglobins / analysis
Hypolipidemic Agents / therapeutic use
Leukocyte Count
Logistic Models
Middle Aged
Multivariate Analysis
Odds Ratio
Patient Admission
Predictive Value of Tests
Risk Assessment
Risk Factors
Severity of Illness Index
Stroke / blood,  diagnosis*,  etiology,  mortality,  physiopathology,  therapy
Switzerland / epidemiology
Time Factors
Reg. No./Substance:
0/Biological Markers; 0/Blood Glucose; 0/Hemoglobins; 0/Hypolipidemic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Structural and Magnetic Properties of Small 4d Transition Metal Clusters: Role of Spin-Orbit Couplin...
Next Document:  Introduction into PPPM as a new paradigm of public health service: an integrative view.